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1214-99 Magnetocardiography in the Detection of Fetal 
Arrhythmias 
Ellen G. Golbach, Jeroen G. Stinstra, Maria J. Petrs, Rik H. Quartero, Frits J. Klumper, 
Erik J. Meiiboom. Wilhelmina Childrens Hospital/UMC Utrecht, Utrecht, The Netherlands. 
Background: Fetal magnetocardiograms are recordings of the magnetic field generated 
by the fetal heart. Whereas other methods provide a measure for the mechanical perfor- 
mance of the fetal head, fetal magnetocardiogrephy reflects the electrophysiological phe- 
nomena directly. Fetal magnetocardiograms can be reliably obtained from 20 weeks 
gestationel age Methods: Fetal magnetocardiegrams were obtained in 16 normals, 3 
SSA/SSB-positive women diagnosed with fetal complete AV-blook, 2 fetal flutters and 2 
with premature atdal contractions (PAC). The fetal magnetocardiogrems were obtained 
using a 1g-channel SQUID Magnetometer system, cooled by liquid Helium. 
Results: Normal fetal heart rates could be reliably obtained from 20 weeks gestational 
age. Fetal head rate varied from 110 to 160 bpm with a beat-to-beat variability of 5-25 
bpm, P-wave duration 46±11 ms, PR-intsrval 98±16 ms, ORS-width 52+9 ms, T-wave 
and QT-segments were discernable in 50%. In the 3 complete AV-blocks measurements 
between 25 and 35 week gestational age, P-P interval varied from 397±38 ms to 460±16 
ms. P-wave duration did differ significantly from normals, R-R interval ranged from 
784±33 ms to 1063±4 ms, while QRS-width was net significantly different from normals. 
In case A an progression from a 2nd to 3rd degree AV-blook was observed, from 784±33 
to 960±62 ms for the R-R interval. Case B and C showed R-R intervals of 1063±4 ms 
and 1001±32 ms. In two patients with supraventdcular tachycardia, fetal flutter was 
observed with atrial rates of respectively 438bpm and 480bpm and ventricular ates of 
219bpm and 240bpm. Both showed a 2:1 atdoventricular block dudng flutter periods. 
Fetal echegraphy and postnatal ECG confirmed all rates and measurements. Only case 
B required immediate post natal pacemaker implantation. 
Conclusions: Fetal magnetocardiography (MCG) is able to register fetal heart rate reli- 
ably from 20 weeks gestational age on and can be used to classify arrhythmias. It is pos- 
sible to determine the atrial and ventricular rates and the duration of P-waves, PR- 
intervals and QRS-complex. Magnetocardiograms. Complete fetal AV-blook can be docu- 
mented and even progression from 2nd to 3rd degree block can be registered 
1214-100 Hydrops Fetalis: Pr imary Cardiovascular Etiologies and 
Clinical Outcome in 98 Affected Pregnancies 
Wendv Tsana. Mary van der Veide, Rory Windrim, Jeffrey Smalthorn, Lisa K. Hornberger, 
The Hospital for Sick Children, Toronto, Ontario, Canada, The Children's Hospital, 
Boston, Massachusetts. 
Background: Cardiovascular disease (CD) is observed in over a quader of pregnancies 
complicated by hydrops fetalis (HF). We sought to determine the distribution and spec- 
trum of structural, functional, and rhythm-ralated CD associated with HF, and the clinical 
outcome of a large cohort of affected pregnancies. Methods: We identified all fetal cases 
of HF and CD from the cardiology databases of The Children's Hospital, Boston and The 
Hospital for Sick Children, Toronto encountered from 1987 to 2001. Pre and postnatal 
echocardiograms and medical records, and , when available, autopsy reports were 
reviewed. Results: HF and CD were diagnosed in 98 fetuses at a mean gestational age 
of 23.4±4.0 weeks. Of 43 with structural CD, 16 had associated severe AV or semilunar 
valve regurgitation, 7 had hypoplastic left heart syndrome (2 with cystic hygroma), 5 had 
heterotaxy syndrome with heart block, 6 had AV septal defects with chromosomal abnor- 
malities, 3 had single ventricles, 3 had premature closure of the ductus artedosus, 2 had 
cardiac tumors, and 1 had pulmonary stenosis with cystic hygroma. Of 32 fetuses with 
primary myocardial disease, 16 had a cardiomyopathy, 8 had myocarditis, and 8 were 
recipient twins in twin-twin transfusion syndrome. Finally, of 23 with primary dysrhyth- 
mias, 15 had supraventricular tachycardia, 6 had complete heart block, 1 had atrial flutter 
and 1 had ventricular ectopy. Of 82 cases with a documented outcome: 6 had pregnancy 
termination (4 structural, 1 myocardial, I dysrhythmia), 32 had spontaneous intrauterine 
demise at a mean age of 26.8±5.2 weeks (17 structural, 12 myocardial, 3 dysrhythmia), 
15 died as newborns (9 structural, 5 myocardial, 1 dysrhythmia), and 29 survived beyond 
the neonatal period (4 structural, 11 myocardial, 14 dysrhythmias). Conclusion: Among 
continued pregnancies, HF in the presence of CD is associated with a high perinatal mor- 
tality, particularly for fetuses with structural heart disease (87% versus 61% with myocar- 
dial disease and 22% with primary dysrhythmia). 
1214-101 Fetal Heterotaxy Syndrome: Spectrum of Heart Disease, 
Accuracy of Diagnosis, and Clinical Outcome 
Mio Taketazu. Jane Lougheed, Jeffrey F. Smallhorn, Shi-Joon Yoo, Lisa K. Hornberger, 
Division of Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada, Division 
of Cardiology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada. 
Background: Heterotaxy syndrome (HS) after birth is associated with a spectrum of 
heart defects and variable clinical outcomes. Methods: To determine the spectrum of 
heart defects, accuracy of diagnosis, and outcome of fetal HS, we reviewed our experi- 
ence since 1992. Prenatal and postnatal echooardiograms and medical records were 
reviewed. Results: Fetal HS was identified in 62 cases. Of 42 with left atrial isomerism 
(LAI), 40 had interrupted inferior vena cava, 28 had AV septal defect (AVSD),12 had dou- 
ble outlet right ventricle (DORV), 15 had pulmonary and 9 had aortic outflow obstruction, 
9 had aortic arch obstruction, 11 had anomalous pulmonary venous drainage (APVD), 
and 7 had AV block. Two functional ventricles were present in 68% and only 1 functional/ 
single ventricle (SV) in 33% with LAI. Of 20 with right atrial isomerism (RAI), 16 had 
AVSD, 9 had DORV, 15 had pulmonary and 2 had aortic outflow obstruction, 16 had total 
APVD, 1 had AV block, and 80% had SV. Of the 62 cases, all intracardiac lesions were 
correctly diagnosed in utero with autopsy or postnatal echo confirmation. Systemic 
venous return abnormalities were correctly diagnosed in 46/53 and APVD in 22/30 (89% 
and 86% after 1996, respectively). Of 39 with LAI and documented outcomes, 11 had 
pregnancy termination, 2 with AV block were stillborn, 3 died as newborns, 3 died after 
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the newborn period (mean age 11.4±13.8rues), and 18 are currently alive (mean age 
45±34mos). In continued LAI pregnancies, SV and AVSD were more common among 
nonsurvivors (38% and 75% respectively) than survivors (20% end 45%, respectively), 
and perinatal death occurred in 3/3 with AV block. Of 18 with RAI and documented out- 
comes, 6 had pregnancy termination, 1 with AV block was stillbom, 4 died as newborns, 
and 5 died in later infancy (mean age 4.9±2.5mos). Only 2 with RAI are currently alive at 
5.3 and 3.3 yrs. Conclusion: As observed postnatally, fetal HS is associated with a 
spectrum of cardiac pathology which can be diagnosed accurately in utaro. Among con- 
tinued pregnancies, a poor outcome is observed particularly for fetal RAI (83% mortality). 
Whereas, fetal LAI is associated with reasonable outcome (28% mortality) with SV, 
AVSD, and heart block more common among nonsurvivors. 
1214-102 Cellular Insights Into the Role of Endothelin-1 in the 
Cardiovascular Pathology of Twin-Twin Transfusion 
Syndrome 
Liane Poraoa. Catherine Barrea, Sandra Singhroy, Lisa K. Hornberger, The Hospital for 
Sick Children, Toronto, Ontario, Canada. 
Background: Twin-twin transfusion syndrome (TTTS) complicates up to 20% of mono- 
chodonic multiple pregnancies. Arterio-venous hunting in the shared placenta leads to 
blood transfer from the donor to the recipient (RT) twin. Significant cardiovascular pathol- 
ogy has been shown in the RT including: biventdcular hypertrophy, systolic and diastolic 
dysfunction, and systemic hypedensien. Histological data suggests increased fetal car- 
diac myocyte (FCM) and vascular smooth muscle cell (FVSMC) proliferation. Recent 
investigations have shown higher levels of endothslin-1 lET-l), a vasoactive peptide and 
mtlogen, in the umbilical vein of the RT compared to the donor twin. The purpose of this 
study was to determine whether ET-1 induces human FCM and FVSMC proliferation and 
whether pulsatile mechanical stretch, used to simulate increased preload, enhances the 
effect of ET-1 on FCM. Methods: FCM ahd FVSMC were isolated from human fetal 
hearts and pulmonary arteries. Cells plated at 5x104 cells/ml were grown in standard 
media with 5% serum, then in serum free media for 24 hours and then exposed to 0, 
0.01, 0.05, 0.5, 5, 10, 100 nM ET-1 or 5% serum. FCM grown on fibronectin-coated sili- 
con membranes were also exposed to 100 nM ET-1 with or without pulsatile mechanical 
stretch (5% strain, 30/minute). Results: ET-1 induced significant FCM proliferation at 
concentrations of 100 and 10 nM as measured by change in cell number (21±5% and 
14+4%, respectively) and [3H]thymidine incorporation for DNA synthesis (28±8% and 
23±6%, respectively) compared to negative controls. ET-1 had a significantly greater 
effect on FVSMC with proliferation observed even at concentrations of 5 and 0.5 nM 
(change in cell number: 32±16% and 21±10% and [3H]thymidine incorporation: 145±74% 
and 78:t:24%, respectively) which more closely approximates the concentrations previ- 
ously measured in vivo. PulsaUle stretch did not enhance the mitogenic effect of ET-1. 
Concluelon: Our in vitro data suggests that ET-1, in TI-['S, may play more of a direct 
role in FVSMC proliferation and medial thickening in the RT, perhaps resulting in indirect 
FCM proliferation secondary to increased afferload. It may also play less of a direct role 
in FCM proliferation. 
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874-1 The Potential Role of Plasma Neurohormones In the 
Follow-Up of Unoperatad or Physiological ly Repaired 
Congenitally Corrected Transposition of the Great 
Arteries 
All Dodge-Khatami, Ioor I. Tulqvski. Gerd B. Bennink, J. F. Hitchcock, B. A. de Mol, Ernst 
E. van der Wall, Barbara J M. Mulder, Dutch Heart Foundation, Amsterdam, The 
Netherlands, AMC, Amsterdam, The Netherlands. 
Background: Plasma neurohormones Brain Natriuretic Peptide (BNP) and Atrial Natd- 
uretic Peptide (ANP) are secreted in increased amounts during the early states of right 
ventricle (RV) dysfunction. In congenitally corrected transposition (CCTGA), the over- 
loaded systemic RV may fail and lead to tricuspid regurgitation. Variations in neurohor- 
mones over time could guide the follow-up of CCTGA patients, in serving as quantitative 
markers of evolving ventricular function. 
Methods: Plasma neurohormones were measured in 7 unoperated and 6 physiologically 
repaired minimally or asymptomatic adult patients with CCTGA, as well as in 11 healthy 
controls. 
Results: Mean ANP levels (3.9 +/- 1.3) were significantly lower in controls than in patients 
with CCTGA, both compared to unoperated patients (8,2 +/- 5; p<0.04), and to physiolog- 
ically repaired patients (12.7 +/- 12; p<0.03). BNP levels were also lower in controls (2.5 
+/- 1.8), significantly compared to physiologically repaired patients (11.8 +/- 8; p<0.003), 
and with a trend compared to unoperated patients (4.4 +/- 3; p<0.07). 
Conclusion: Increased plasma BNP and ANP levels are sensitive markers of venfricular 
strain, and are higher in patients with unoperated and physiologically repaired CCTGA, 
as compared to controls. Monitonng changes in plasma neurohormones may serve to 
predict early deterioration of RV function in paucisymptomatic patients, and anticipate 
adequate treatment. Further studies are warranted, with emphasis on timing of neurohor- 
mona measurements. 
